In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia

British Journal of Haematology

Volumn 95, Issue 1, 1996, Pages 127-130

  Carella, Angelo M ^a   Dejana, Anna ^a   Lerma, Enrica ^a   Podesta, Marina ^a   Benvenuto, Federica ^a   Chimirri, Francesca ^a   Parodi, Caterina ^a   Sessarego, Mario ^b   Prencipe, Emma ^b   Frassoni, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b DIMI   (Italy)

Author keywords

'normal' PBPC mobilization; high risk sAML

Indexed keywords

CYTARABINE; ETOPOSIDE; IDARUBICIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; APHERESIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KARYOTYPE; MALE; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 10244260460     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.7292351.x     Document Type: Article

References (11)

1. Carella, A.M., Chimirri, F., Podestà, M., Pitto, A., Piaggio, G., Dejana, A., Lerma, E., Pollicardo, N., Vassallo, F., Soracco, M., Benvenuto, F., Valbonesi, M., Carlier, P., Vimercati, R., Prencipe, E., Gatti, A.M., Ferrara, R.A., Incagliato, M., Florio, G. & Frassoni, F. (1996) High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Bone Marrow Transplantation, 17, 201-205.
2. Carella, A.M., Frassoni, F., Pollicardo, N., Pungolino, E., Ferrero, R., Vassallo, F., Soracco, M., Giodano, D., Figari, O., Benvenuto, F., Florio, G., Carlier, P. & Valbonesi, M. (1995) Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology, 89, 535-538.
3. Carella, A.M., Podestà, M., Frassoni, F., Raffo, M.R., Pollicardo, N., Pungolino, E., Vimercati, R., Sessarego, M., Parodi, C., Rabitti, C., Ferrero, R., Benvenuto, F., Figari, O., Carlier, P., Levcasic, G., Valbonesi, M., Vitale, V., Giordano, D., Pierluigi, D., Nati, S., Guerracio, A., Rosso, C. & Saglio, G. (1993) Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in CML. Bone Marrow Transplantation, 12, 267-271.
4. Demuynck, H., Delforge, M., Verhoef, G.E.G., Zachee, P., Vandenberghe, P., Van Den Berghe, H. & Bougaerts, M.A. (1996) Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromes. British Journal of Haematology, 92, 351-555.
5. De Witte, T., Suciu, S., Peetermans, M., Fenaux, P., Strijckmans, P., Hayat, M., Jaksic, B., Selleslag, D., Zittoun, R., Dardenne, M., Solbu, G., Zwierzina, H. & Muus, P. (1995) Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG). Lenkemia, 9, 1805-1811.
6. Geddes, A., Bowen, D. & Jacobs, A. (1990) Clonal karyotypic abnormalities and clinical progress in the myelodysplastic syndrome, British Journal of Haematology, 76, 194-202.
7. Greenberg, P., O'Brien, S., Goldman, J. & Sawyers, C. (1995) Myelodysplastic syndromes and myeloproliferative disorders: clinical, therapeutic and molecular advances. Hematology 1995, Educational Program ASH. Seattle. Washington, 2-5 December, pp. 10 21.
8. Kantarjian, H.M., Keating, M.J., Walters, R.S., Smith, T.L., Cork, A., MeCredie, K.B. & Freireich, E.J. (1986) Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic and prognostic features, Journal of Clinical Oncology, 4, 1748-1757.
9. Laporte, J.P., Isnard, F., Lesage, S., Fenaux, P., Douay, L., Loper, M., Stachowiak, J., Najman, A. & Gorin, N.C. (1993) Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): a pilot study. Leukemia, 7, 2030-2033.
10. Öerg, G., Simonsson, B. & Smedmyr, B. (1989) Is hematological reconstitution seen after ABMT in MDS patients? Bone Marrow Transplantation, 4,(Suppl. 2), 52.
11. Yunis, J.J., Rydell, R.E., Oken, M.M., Arnesen, M.A., Mayer, M.G. & Lobell, M. (1989): Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndrome. Blood, 67, 1721 1730.